Selenium and genotypes as marker of risk in BRCA1 mutation carriers

Selenium and genotypes as marker of risk in BRCA1 mutation carriers

Bibliographic Details
Main Authors:	Jaworska K, Jakubowska A, Huzarski T, Durda K, Serrano-Fernandez P, Sukiennicki G, Muszyńska M, Byrski T, Gronwald J, Gupta S, Lubiński J J
Format:	Article
Language:	English
Published:	BMC 2012-01-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S1/A8

Similar Items

Selenium and cancer risk in CHEK2 mutation carriers
by: Gupta Satish, et al.
Published: (2012-04-01)

Selenium and the risk of cancer in BRCA1 carriers
by: Lubinski J, et al.
Published: (2011-06-01)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
by: Lubiński J, et al.
Published: (2012-01-01)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
by: Jaworska Katarzyna, et al.
Published: (2012-04-01)

Selenium (Se) and breast cancer risk
by: Jaworska - Bieniek Katarzyna, et al.
Published: (2012-12-01)

Folic acid and cancer risk in BRCA1 carriers
by: Durda Katarzyna, et al.
Published: (2012-04-01)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
by: Sukiennicki Grzegorz, et al.
Published: (2012-04-01)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
by: Muszyńska Magdalena, et al.
Published: (2012-04-01)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
by: Byrski T, et al.
Published: (2012-04-01)

Ovarian cancer risk in Polish <it>BRCA1 </it>mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism
by: Benner Axel, et al.
Published: (2008-04-01)

Vitamins A, E and D and cancer risk in BRCA1 carriers
by: Kąklewski K, et al.
Published: (2012-04-01)

Cisplatin in breast cancer treatment in BRCA1 carriers
by: Gronwald Jacek, et al.
Published: (2012-12-01)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
by: Huzarski Tomasz, et al.
Published: (2006-01-01)

Blood and serum samples collection and storage for further selenium measurements
by: Muszyńska Magdalena, et al.
Published: (2012-04-01)

Zinc and breast cancer risk
by: Kaczmarek Katarzyna, et al.
Published: (2012-12-01)

Selected aspects of genetic counselling for <it>BRCA1 </it>mutation carriers
by: Gronwald Jacek
Published: (2007-03-01)

Selenium and gastrointestinal cancers risk
by: Lener Marcin, et al.
Published: (2012-12-01)

CHEK2 mutations as markers for high risk of breast cancer
by: Cybulski Cezary, et al.
Published: (2012-04-01)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
by: Alena Savanevich, et al.
Published: (2021-01-01)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
by: Jaworska Katrzyna, et al.
Published: (2012-04-01)

Serum selenium level and cancer risk: a nested case-control study
by: Steven A. Narod, et al.
Published: (2019-12-01)

Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
by: Ertmański S, et al.
Published: (2012-01-01)

Identification of new genes associated with breast and ovarian cancer risk. Advances of BCAC, CIMBA and OCAC
by: Jakubowska A, et al.
Published: (2011-06-01)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
by: Byrski T, et al.
Published: (2012-01-01)

Management of the asymptomatic BRCA mutation carrier
by: Paige Teller, et al.
Published: (2010-11-01)

Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> Carriers
by: Wojciech Marciniak, et al.
Published: (2021-07-01)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
by: Byrski T, et al.
Published: (2011-06-01)

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2017-01-01)

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review
by: O. Bougie, et al.
Published: (2011-01-01)

Arsenic (As) and breast cancer risk
by: Muszyńska Magdalena, et al.
Published: (2012-12-01)

Impact of BRCA1 mutation on survival after early onset breast cancer
by: Huzarski T, et al.
Published: (2012-12-01)

Risk modelling in BRCA1 and BRCA2 mutation carriers
by: Mavaddat, Nasim
Published: (2012)

Cancer risks in BRCA1 and BRCA2 mutation carriers
by: Thompson, Deborah Jane
Published: (2002)

Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2018-01-01)

A low selenium level is associated with lung and laryngeal cancers.
by: Katrzyna Jaworska, et al.
Published: (2013-01-01)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
by: G. Cipollini, et al.
Published: (1999-01-01)

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers
by: Katrzyna Jaworska, et al.
Published: (2013-01-01)

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers.
by: Katrzyna Jaworska, et al.
Published: (2013-01-01)

The risk of breast cancer in women with a CHEK2 mutation
by: Cybulski Cezary, et al.
Published: (2012-01-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)